Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and unresectable pancreatic cancer.
about
Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation.Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancerIntensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysisComparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer.CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic CancerElevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer.Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.Standardized uptake value on positron emission tomography/computed tomography predicts prognosis in patients with locally advanced pancreatic cancer.Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma.
P2860
Q30423279-0A905AA2-74C4-4380-A17D-8E8F72F383F1Q33923018-3D7BCFF8-0E9E-45A1-A4C4-50F2E1AAE57EQ34976612-1144A715-BDC1-4561-99F5-9AA7790879B4Q36985745-0646CC3E-769C-4356-B65A-16C68DF112E7Q37033444-B679F47B-3F14-4C09-BA14-889A50C88B43Q37339612-7476ABAC-1BC6-47D1-B796-55D4C1AF7A4FQ37483443-28AE7C81-AAB9-4C8E-BD76-9D1C7D7DD192Q41715410-D51A4886-875B-4903-B8C6-D04D3D50B254Q52991088-87953758-F21E-4C2D-B129-B866DA1A3F9DQ54298269-9068F187-9678-49FC-8777-8EBEF63079CF
P2860
Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and unresectable pancreatic cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pretreatment carbohydrate anti ...... nresectable pancreatic cancer.
@en
type
label
Pretreatment carbohydrate anti ...... nresectable pancreatic cancer.
@en
prefLabel
Pretreatment carbohydrate anti ...... nresectable pancreatic cancer.
@en
P2093
P1476
Pretreatment carbohydrate anti ...... nresectable pancreatic cancer.
@en
P2093
Dae Yong Kim
Eun Kyung Hong
Joong-Won Park
Kyung Hwan Shin
Sang Myung Woo
Sang Soo Kim
Sang-Jae Park
Sung Ho Moon
Sung-Sik Han
Tae Hyun Kim
P304
P356
10.1016/J.IJROBP.2011.02.063
P407
P577
2011-05-19T00:00:00Z